U.S. Luxury Stock News

In the first quarter of 2026, Humacyte, Inc. reported revenue of US$495,000, sales of US$2,000, and a net loss of US$17.62 million, alongside a Nasdaq notice that its share price had stayed below the US$1.00 minimum listing requirement. The sharp swing from a US$39.14 million net profit a year earlier to a loss, combined with the compliance warning, raises questions about Humacyte’s operating trajectory and financing flexibility even as it appoints a new Chief Surgical Officer to support...

Pangaea Logistics Solutions Ltd. ( NASDAQ:PANL ) defied analyst predictions to release its first-quarter results, which...

AST SpaceMobile reported first-quarter 2026 results with revenue rising to US$14.74 million from US$718,000 a year earlier, while net loss widened to US$191.01 million and loss per share increased to US$0.66. Despite the weaker quarter and higher operating costs, the company reaffirmed its 2026 revenue guidance of US$150 million to US$200 million and highlighted progress on new BlueBird satellite launches, U.S. regulatory approvals, and its role in a planned AT&T–T-Mobile–Verizon satellite...

Recent performance snapshot and why Waste Management is on investor radars Waste Management (WM) has drawn fresh attention after a period of softer share performance, with the stock down about 6% over the past month and the past 3 months, and roughly 1% over the past year. See our latest analysis for Waste Management. With the share price at US$216.44 and shorter term share price returns over the past month and quarter both declining about 6%, momentum has cooled compared with the stronger...

Lam Research stock overview after recent performance Lam Research (LRCX) has drawn investor attention after recent share price moves, including a 2.1% gain over the last day and a 10.5% rise over the past month, alongside a much stronger 1 year total return. See our latest analysis for Lam Research. The recent 10.5% 30 day share price return and 27.7% 90 day share price return suggest momentum has been building, while the 1 year total shareholder return above 250% points to a very strong...

We'd be surprised if Twist Bioscience Corporation ( NASDAQ:TWST ) shareholders haven't noticed that the VP & Chief...

Wondering whether RLI at around US$47.77 is starting to look interesting, or if the stock still does not justify a closer look on price alone. The share price has fallen 2.5% over the past week, 18.7% over the past month, and 23.5% year to date, adding to a 32.4% decline over the last year and 18.8% over three years, while the five year return stands at 8.4%. Recent moves in the stock are drawing more attention to how the market is currently treating insurers like RLI, especially after a...

Schneider National (SNDR) sits on many watchlists today after recent price moves left the stock with a year to date return of 8.2% and a 1 year total return of 21.3%. See our latest analysis for Schneider National. That mixed backdrop, with a 7 day share price return down 5.6% but a year to date share price return of 8.2% and a 1 year total shareholder return of 21.3%, suggests recent selling has cooled but not reversed the stock’s broader positive momentum. If Schneider National has you...

Ligand Pharmaceuticals (LGND) is back in focus after its latest quarterly update, which combined higher royalty revenues and adjusted EPS with the planned XOMA acquisition and a contested termination of the Viking TR Beta licensing program. See our latest analysis for Ligand Pharmaceuticals. The stock has eased in the very short term, with a 7 day share price return of down 4.9%. However, the 90 day share price return of 21.8% and the 1 year total shareholder return of 110.5% point to strong...

Ubiquiti Inc. recently reported fiscal third-quarter 2026 results showing higher sales and earnings compared with a year earlier, and reaffirmed its quarterly cash dividend of US$0.80 per share payable on May 26, 2026. The earnings mix was heavily skewed toward the Enterprise Technology segment, which accounted for over 90% of quarterly sales, underscoring how central that business has become to Ubiquiti’s overall profile. We’ll now examine how the Enterprise Technology-driven earnings...

Investors were disappointed with the weak earnings posted by Shopify Inc. ( NASDAQ:SHOP ). However, our analysis...

Broadcom stock snapshot and recent performance Broadcom (AVGO) stock has seen mixed short term moves, with the price slipping about 0.6% over the past day and 2% over the past week, yet gaining roughly 10% over the past month. Over the past 3 months, the stock is up about 26%, and the 1 year total return stands near 81%. Longer term, reported total returns over 3 and 5 years are very large and reflect substantial compounding over time. At the last close of US$416.79, Broadcom carries a market...

WhiteFiber (WYFI) is back in focus as the company reports Q1 2026 results before the market opens today, with traders watching closely after a buildup in short interest and recent bearish sentiment. See our latest analysis for WhiteFiber. WhiteFiber’s share price has surged in recent weeks, with a 30-day share price return of 77.71% and a 90-day share price return of 48.60%. This suggests short term momentum has picked up ahead of earnings, while the year to date share price return of 60.61%...

In recent months, Valmont Industries has reported strong earnings per share growth and a wider free cash flow margin, while analysts and brokers have maintained favorable rankings and recommendations based on its fundamentals. This combination of rising profitability metrics and broadly positive analyst sentiment has reinforced the view that Valmont’s operational improvements are materially strengthening its underlying business quality. With this backdrop of improving profitability and...

Assessing Digi International after the Assure product launch Digi International (DGII) has just expanded its SmartSense platform with Assure, a new compliance and quality audit tool for multi location food service, grocery, healthcare, and other enterprise customers. The launch puts more focus on Digi’s role in helping large chains digitize inspections, track follow up tasks, and keep closer tabs on day to day execution across sites. This context could matter for how you think about the...

Agoda has partnered with the Macao Government Tourism Office to promote boutique and independent hotels to international travelers. Priceline is bringing back its "Negotiator" campaign alongside a major summer sale aimed at value conscious travelers. Both initiatives sit under Booking Holdings, traded as NasdaqGS:BKNG, and focus on demand generation rather than product changes alone. NasdaqGS:BKNG runs a portfolio of online travel brands that spans hotels, flights and broader trip planning...

In the first quarter of 2026, Ryan Specialty Holdings, Inc. reported revenue of US$795.23 million, net income of US$40.6 million, and a move from a loss to positive earnings per share, while also completing a previously announced US$40 million repurchase of 982,073 shares. This shift from a net loss a year earlier to profitability highlights a meaningful improvement in the company’s operating performance and earnings quality. We’ll now examine how Ryan Specialty’s return to profitability in...

In the first quarter of 2026, Merit Medical Systems reported sales of US$381.88 million and net income of US$41.00 million, and it raised full-year 2026 revenue guidance to a range of US$1.61 billion–US$1.63 billion. Alongside these results, mixed insider activity, with a director selling shares and senior executives buying through 401(k) plans, offers a nuanced view of internal confidence. With Merit lifting its full-year revenue outlook, we will now examine how this guidance upgrade...

Royalty Pharma earnings and buyback catch investors’ attention Royalty Pharma (RPRX) has drawn fresh investor focus after reporting first quarter 2026 earnings with revenue of US$630.58 million and net income of US$294.69 million, alongside continued progress on its multi year share repurchase program. See our latest analysis for Royalty Pharma. The stock has picked up momentum, with a 1 day share price return of 3.0% and a year to date share price return of 37.03%, while the 1 year total...

Investors may be wondering whether Equinix at around US$1,077 per share still offers value, or if most of the opportunity is already reflected in the price. The stock is up 41.0% year to date and 28.3% over the past year, even though it has slipped 1.0% over the last week and is up 1.9% over the past month. Recent coverage has focused on Equinix's position as a key player in data center and digital infrastructure, as investors weigh how demand for connectivity and cloud ecosystems feeds into...

Nvidia CEO Jensen Huang joined President Donald Trump’s high-profile delegation to China at the last minute. The visit centers on AI chip trade, including Nvidia’s H200 products, and broader semiconductor market access discussions between US and Chinese officials. Chinese authorities have approved some purchases of Nvidia AI chips, although no shipments have been delivered so far. The trip comes while US export restrictions and Chinese domestic chip efforts are shaping the terms of...

PDF Solutions, Inc. ( NASDAQ:PDFS ) recently posted some strong earnings, and the market responded positively. We have...

This article looks at what the numbers indicate about whether TransDigm Group, at around US$1,201 per share, still offers value or whether most of the opportunity is already reflected in the price. The share price has fallen 2.6% over the last week and over the last 30 days, is down 11.6% year to date, and 7.7% over the past year, while the 3 year and 5 year returns stand at 71.4% and 146.0% respectively. Recent coverage of TransDigm Group has largely focused on its role within the broader...

GRAIL, Inc. has reported past first-quarter 2026 results, with sales of US$39.83 million and revenue of US$40.79 million, alongside a reduced net loss of US$93.19 million and lower basic loss per share versus a year earlier. The combination of higher revenue and a smaller net loss suggests GRAIL’s multi-cancer early detection business is scaling while expenses are being managed more tightly. We’ll now examine how GRAIL’s improved first-quarter loss profile influences its existing investment...